Featured Post

Latest Gold News

Economic power could shift further East with Hong Kong gold exchange Russian investment bank sees $1,400 gold by end of 2017 Weak CPI...

Tuesday, November 15, 2011

Anadys (ANDS) (SDT) (AMGN) (SPF) (TEF) (ALIM) Downgraded

Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS), SandRidge Mississippian Trust I (NYSE: SDT), Amgen, Inc. (NASDAQ: AMGN), Standard Pacific Corp. (NYSE: SPF), Telefonica SA (NYSE: TEF) and Alimera Sciences Inc. (NASDAQ: ALIM) were downgraded by analysts.

Anadys Pharmaceuticals, Inc. (ANDS) was downgraded by William Blair from an “Outperform” rating to a “Market Perform” rating.

SandRidge Mississippian Trust I (SDT) was downgraded by Robert W. Baird from an “Outperform” rating to a “Neutral” rating. They have a price target of $24.00 on the stock, down from $30.00.

Amgen, Inc. (AMGN) was downgraded by Leerink from an “Outperform” rating to a “Market Perform” rating.

Standard Pacific Corp. (SPF) was downgraded by Compass Point to a “Neutral” rating. They have a price target of $3.50 on the company.

Telefonica SA (TEF) was downgraded by JPMorgan Chase & Co. (NYSE:JPM) from an “Overweight” rating to a “Neutral” rating.

Alimera Sciences Inc. (ALIM) was downgraded by Citigroup (NYSE:C) from a “Buy” rating to a “Neutral” rating.

No comments: